ViewFinder · 3D mammography AI
Detection finds suspicion.
ViewFinder finds the match.
Detection AI asks “is there cancer?” ViewFinder answers “where is it in the other view?” by matching tissue between CC and MLO views of a 3D mammogram.
FDA-cleared · 510(k) K223501
A different AI question
The correlate is the clinical problem.
DBT gives radiologists depth, but matching the same tissue between non-orthogonal views remains a demanding mental task. ViewFinder supports that correlation while leaving detection and interpretation with the reader.
Detection AI asks
“Is there cancer?”
Identifies or scores suspicious findings.
ViewFinder asks
“Where is it in the other view?”
Dynamically maps corresponding tissue between CC and MLO DBT views, complementing CAD.
Peer-reviewed evidence
Localization changes when the views connect.
A multicentre reader study published in the European Journal of Radiology evaluated dynamic AI-assisted ipsilateral tissue matching in DBT.
86.5%
Localization errors are 86.5% higher without ViewFinder in key cases.
Read the peer-reviewed study
Without ViewFinder
≈17mm
Localization error for abnormal findings in early-career breast imagers.
With ViewFinder
≈9mm
The same error measure with AI-assisted tissue matching.
Clinical context
≈13mm
Median size of screen-detected tumours reported in the study context.
Supporting clinical cases
Further ultrasound-targeting examples.
Independent signals
From evidence to practice.
“ViewFinder is complementary to CAD.”
Reader response
92% would use Elaitra in practice.
“More accurate and more efficient in finding the lesion.”
“It’s a no brainer that it’s useful.”
“It quickens things up.”
“It’s gorgeous!”
For radiologists
See ViewFinder on live cases.
Sign up, log in, explore cases with ViewFinder, then upload your own case to see tissue matching in your workflow.
